Pfizer Falls as Arthritis Drug Is Rejected in Europe

Pfizer Inc., the world’s biggest drugmaker, said its new arthritis pill was rejected by European regulators as not effective enough against the condition.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.